Category Archives: Stem Cell Research

Boy Hears Parents' Voices for First Time Grayson Clamp, 3, is the first child to have a device implanted into the base of his brain stem to help him hear, and he had amazing results. By: NewsyScience … Continue reading →

You are here: Latest News Japan Announces First Human Stem Cell Clinical Trial A Japanese government panel has approved the world's first clinical research using human induced pluripotent stem cells, officials said. The panel of the country's Health Ministry has issued approval for governmental scientific research institute Riken and the Foundation for Biomedical Research and Innovation to conduct a clinical research plan to use iPS cells for retinal regeneration, Kyodo News reported Wednesday. Kyoto University Professor Shinya Yamanaka co-won the 2012 Nobel Prize in physiology or medicine for his development of iPS cells, which can grow into any type of human body tissue and are seen as candidates for regenerative medicine and drug development. The clinical research team will try to develop treatment techniques using iPS cells to cure age-related macular degeneration, a condition that can cause sudden vision loss due to retinal damage. The team said it would extract skin cells from several patients, create iPS cells from them, develop them into pigment epithelium of the retina and transplant them into the patients' retinas. The researchers said they would attempt the transplants next year. Copyright 1997 - 2013 ThirdAge Media, LLC. All rights reserved. See more here: Japan Announces … Continue reading →

Dallas, TX (PRWEB) June 26, 2013 Regenerative medicine in orthopedic applications is a $2.7 billion per year niche sector in Americas $2.6 trillion per year healthcare system. However, it is a sector of immense interest in terms of technical and medical possibilities. The best analogy to the current state of regenerative therapies in the bone and joint healing sector is the nascency of the microprocessors business back in 1971. At that time, microprocessors (namely Intels 4004), and related innovations, were just an infinitesimal segment of electronic component sales, but this innovation came to dominate the economy. The regenerative therapies sector, particularly areas such as cell therapy and stem cell derived products is in a comparable position today. The regenerative medicine industry (http://www.reportsnreports.com/reports/256521-regenerative-medicines-bone-and-joint-applications.html) has been in existence for nearly 25 years. Actual product sales, along with research and development (R&D) expenditures, are projected to amount to approximately $2.7 billion in economic activity in 2013, of which venture capital and R&D funding accounts for about $145 million. Innumerable buyouts, consolidations, product abandonments, new firms and a few bankruptcies, too, have occurred in just the last several years. These changes are reflected in the Company Profiles section of this report. In addition, intensive … Continue reading →

ALBANY, New York, June 25, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture)-Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2012-2018," the market for stem cells was valued at USD 26.23 billion in 2011 and is expected to reach an estimated value of USD 119.51 billion in 2018, growing at a CAGR of 24.2% from 2012 to 2018. Browse the full report athttp://www.transparencymarketresearch.com/stem-cells-market.html The market growth is majorly attributed to therapeutic research activities led by government support worldwide owing to the growing number of patients with chronic diseases across the globe. In addition, rising awareness of regenerative treatment options and growing importance of stem cell banking services are also fostering the growth of the market. Apart from these, development of medical tourism hubs in developing nations such as India and China and in turn migration of patients from developed nations such as the U.S., and Europe for quality treatment at significantly lower prices will also serve the market as a driver especially for the Asian stem cells market. Stem cells market will be driven by … Continue reading →

TOKYO, June 26 (UPI) -- A Japanese government panel has approved the world's first clinical research using human induced pluripotent stem cells, officials said. The panel of the country's Health Ministry has issued approval for governmental scientific research institute Riken and the Foundation for Biomedical Research and Innovation to conduct a clinical research plan to use iPS cells for retinal regeneration, Kyodo News reported Wednesday. Kyoto University Professor Shinya Yamanaka co-won the 2012 Nobel Prize in physiology or medicine for his development of iPS cells, which can grow into any type of human body tissue and are seen as candidates for regenerative medicine and drug development. The clinical research team will try to develop treatment techniques using iPS cells to cure age-related macular degeneration, a condition that can cause sudden vision loss due to retinal damage. The team said it would extract skin cells from several patients, create iPS cells from them, develop them into pigment epithelium of the retina and transplant them into the patients' retinas. The researchers said they would attempt the transplants next year. Continued here: Japan approves world's first human stem cell clinical trial … Continue reading →

Dr. Loret de Mola is interviewed on Stem Cell Research in Cleveland OH A discussion regarding the approval of research using stem cell lines already in existence by the Bush Administration. By: J. Ricardo Loret de Mola, MD … Continue reading →

Bangkok (The Nation/ANN) - Embryonic stem cells are being developed into cardiac muscle tissue in promising new research currently being done in Thailand. Conducted at the Chulalongkorn University's Faculty of Medicine, the project has already moved beyond the experimental stage. "Within three years, this project is expected to successfully turn embryonic stem cells into cardiac muscle tissue," said Assoc Prof Kamthorn Pruksananonda, who heads the stem-cell development research project. If the project completes its intended goals, it will enable doctors to provide cardiac muscle tissue to patients in the very near future, said Kamthorn, adding that four doctors and scientists were involved in the project. According to Kamthorn, embryonic stem cells can be developed into a variety of different cells, including nerve cells. "Embryonic stem cells are better than adult stem cells because they can be manipulated and used to produce a variety of cells, and thus have numerous benefits," he said. Kamthorn disclosed that the Bank of Embryos, Stem Cells and Sperm at the faculty's Chulalongkorn Hospital had over one million embryonic stem cells. "There are five strains in all," he said. He also disclosed that the bank had about 3,000 frozen fertilised eggs. "The oldest one is over … Continue reading →

June 20, 2013 Pancreatic cancer carries a dismal prognosis. According to the National Cancer Institute, the overall five-year relative survival for 2003-2009 was 6 percent. Still, researchers and clinicians don't have a non-invasive way to even detect early cells that portent later disease. 'There's no PSA test for pancreatic cancer,' they say, and that's one of the main reasons why pancreatic cancer is detected so late in its course. They have been searching for a human-cell model of early-disease progression. Now, Perelman School of Medicine, University of Pennsylvania scientists have used stem-cell technology to create a research cell line from a patient with advanced pancreatic ductal adenocarcinoma (PDAC). This first-of-its-kind human-cell model of pancreatic cancer progression was published this week in Cell Reports from the lab of Ken Zaret, PhD, professor of Cell and Developmental Biology. "It is the first example using induced pluripotent stem [iPS] cells to model cancer progression directly from a solid tumor, and the first human cell line that can model pancreatic cancer progression from early to invasive stages," says Zaret, also the associate director of the Penn Institute for Regenerative Medicine. "We were able to predict the appearance of cellular features and protein markers in … Continue reading →

Stem Cells; The Future of Medicine: Yousef Manialawy at TEDxYouth@DAA Since he was young, Yousef Manialawy, a recent graduate of Dubai American Academy, has lived with Type I Diabetes, an illness affecting millions of people wo... By: TEDxYouth … Continue reading →

ISSCR 2013 -- Exciting new stem cell research and technologies Attendees of ISSCR 2013 share what they view as the most promising new stem cell research and exciting new technologies. Visit http://www.lifetechnologies.co... By: LifeTechnologiesCorp … Continue reading →